COVID-19 Vaccines and the Development of New LUTS

This study was conducted to check whether coronavirus disease 2019 (COVID) vaccines have a relationship with LUTS or not in a healthy and mostly medically free population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Vaccine Adverse Reaction Lower Urinary Tract Symptoms Pathological Conditions, Signs and Symptoms Signs and Symptoms Urological Manifestations

Sex eligibility

All sexes

Study type

Observational

Primary location

The Hashemite University

Zarqa, 13133, Jordan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Medical Student
Having had a COVID-19 Vaccine

Exclusion criteria

None

Treatment and study plan

Primary outcomes

New Lower Urinary Tract Symptoms

Time frame: 2-3 months

Only after having had any COVID -19 vaccine

Sponsors and collaborators

Lead sponsor

The Hashemite University

Other

Registry information

Official study title

Relationship Between the Coronavirus 2019 Disease (COVID-19) Vaccines and the Development of New Lower Urinary Tract Symptoms: A Cross-sectional Study on Medical Students.

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Oct 17, 2022
Registry last updated: Oct 17, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed